InvestLog
FDMT logo

FDMT

4D Molecular Therapeutics, Inc.NASDAQHealthcare
$9.48-3.95%ClosedMarket Cap: $484.0M

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-20HC Wainwright & Co.—Buy—
2026-03-19Chardan Capital—Buy—
2026-03-19RBC Capital—Outperform—
2025-12-18Chardan Capital—Buy—
2025-11-11Barclays—Overweight—
2025-11-11Chardan Capital—Buy—
2025-11-11RBC Capital—Outperform—
2025-08-12Chardan Capital—Buy—
2025-08-12Roth Capital—Buy—
2025-07-03Chardan Capital—Buy—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-3.80$12.7M5
Sun Dec 31$-3.87$39.3M4
Mon Dec 31$-3.59$117.8M2
Tue Dec 31$-2.43$257.4M2